Suppr超能文献

用工程化磷酸三酯酶突变体C23对VX中毒豚鼠进行暴露后治疗:一项概念验证研究。

Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.

作者信息

Worek Franz, Seeger Thomas, Reiter Georg, Goldsmith Moshe, Ashani Yacov, Leader Haim, Sussman Joel L, Aggarwal Nidhi, Thiermann Horst, Tawfik Dan S

机构信息

Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937 Munich, Germany.

Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937 Munich, Germany.

出版信息

Toxicol Lett. 2014 Nov 18;231(1):45-54. doi: 10.1016/j.toxlet.2014.09.003. Epub 2014 Sep 6.

Abstract

The highly toxic organophosphorus (OP) nerve agent VX is characterized by a remarkable biological persistence which limits the effectiveness of standard treatment with atropine and oximes. Existing OP hydrolyzing enzymes show low activity against VX and hydrolyze preferentially the less toxic P(+)-VX enantiomer. Recently, a phosphotriesterase (PTE) mutant, C23, was engineered towards the hydrolysis of the toxic P(-) isomers of VX and other V-type agents with relatively high in vitro catalytic efficiency (kcat/KM=5×10(6)M(-1)min(-1)). To investigate the suitability of the PTE mutant C23 as a catalytic scavenger, an in vivo guinea pig model was established to determine the efficacy of post-exposure treatment with C23 alone against VX intoxication. Injection of C23 (5mgkg(-1) i.v.) 5min after s.c. challenge with VX (∼2LD50) prevented systemic toxicity. A lower C23 dose (2mgkg(-1)) reduced systemic toxicity and prevented mortality. Delayed treatment (i.e., 15min post VX) with 5mgkg(-1) C23 resulted in survival of all animals and only in moderate systemic toxicity. Although C23 did not prevent inhibition of erythrocyte acetylcholinesterase (AChE) activity, it partially preserved brain AChE activity. C23 therapy resulted in a rapid decrease of racemic VX blood concentration which was mainly due to the rate of degradation of the toxic P(-)-VX enantiomer that correlates with the C23 blood levels and its kcat/KM value. Although performed under anesthesia, this proof-of-concept study demonstrated for the first time the ability of a catalytic bioscavenger to prevent systemic VX toxicity when given alone as a single post-exposure treatment, and enables an initial assessment of a time window for this approach. In conclusion, the PTE mutant C23 may be considered as a promising starting point for the development of highly effective catalytic bioscavengers for post-exposure treatment of V-agents intoxication.

摘要

剧毒有机磷(OP)神经毒剂VX的特点是具有显著的生物持久性,这限制了阿托品和肟类标准治疗的效果。现有的OP水解酶对VX的活性较低,且优先水解毒性较小的P(+) - VX对映体。最近,一种磷酸三酯酶(PTE)突变体C23经过改造,可水解VX的有毒P(-)异构体以及其他V型毒剂,其体外催化效率相对较高(kcat/KM = 5×10(6)M(-1)min(-1))。为了研究PTE突变体C23作为催化清除剂的适用性,建立了豚鼠体内模型,以确定单独使用C23进行暴露后治疗对VX中毒的疗效。在皮下注射VX(约2LD50)5分钟后静脉注射C23(5mgkg(-1))可预防全身毒性。较低剂量的C23(2mgkg(-1))可降低全身毒性并防止死亡。在VX暴露15分钟后给予5mgkg(-1) C23进行延迟治疗,所有动物均存活且仅出现中度全身毒性。虽然C23不能防止红细胞乙酰胆碱酯酶(AChE)活性受到抑制,但它能部分保留脑AChE活性。C23治疗导致外消旋VX血药浓度迅速下降,这主要归因于有毒P(-) - VX对映体的降解速率,该速率与C23血药浓度及其kcat/KM值相关。尽管该概念验证研究是在麻醉状态下进行的,但首次证明了催化生物清除剂单独作为单次暴露后治疗时预防全身VX毒性的能力,并对该方法的时间窗进行了初步评估。总之,PTE突变体C23可被视为开发用于V型毒剂中毒暴露后治疗高效催化生物清除剂的一个有前景的起点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验